SCHEMBL14243155

SCHEMBL14243155

CCCCOc1ccc(C(O)c2ccc(OCCCC)c(OC)c2)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FDPS P14324 3/20 0.55
SMN1; SMN2 Q16637 1/20 0.48
PPARG P37231 1/20 0.47
PPARD Q03181 1/20 0.47
PPARA Q07869 1/20 0.47
FAAH O00519 1/20 0.46
KDM4E B2RXH2 1/20 0.46
POLB P06746 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
ACHE P22303 1/20 0.46
PRSS1 P07477 4/20 0.45
THRA P10827 1/20 0.44
THRB P10828 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
PLA2G4B P0C869 1/20 0.43
PRKCE Q02156 1/20 0.43
PRKCQ Q04759 1/20 0.43
PRKCD Q05655 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10080328 0.94 SMPD1 (0.48) FDPSPPARGPPARDPPARAACHE
SCHEMBL17832225 0.90 PPARG (0.55) FDPSSMN1; SMN2PPARGPPARDPPARA
SCHEMBL12016738 0.89 FDPS (0.54) FDPSSMN1; SMN2PPARGPPARDPPARA
SCHEMBL22420286 0.87 PLA2G4B (0.50) PPARGPPARDPPARAFAAHACHE
SCHEMBL17832023 0.86 PPARG (0.51) FDPSSMN1; SMN2PPARGPPARDPPARA
SCHEMBL22420330 0.86 ACHE (0.46) FDPSPPARGPPARDPPARAACHE
SCHEMBL11951552 0.85 KDM4E (0.50) FDPSSMN1; SMN2FAAHKDM4EPOLB
SCHEMBL8320009 0.85 FDPS (0.50) FDPSSMN1; SMN2PPARGPPARDPPARA
SCHEMBL14242910 0.84 FDPS (0.48) FDPSSMN1; SMN2PPARGPPARDPPARA
SCHEMBL14243528 0.84 FDPS (0.46) FDPSSMN1; SMN2PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140336259-A1 PHENOLIC COMPOUNDS WITH ANTIOXIDANT AND ANTI-CANCER PROPERTIES, ANALOGS AND SYNTHESIS THEREOF FEDERATION DES PRODUCTEURS ACERICOLES DU QUEBEC (CA) 2014-11-13 US disclosed
WO-2012167364-A1 PHENOLIC COMPOUNDS WITH ANTIOXIDANT AND ANTI-CANCER PROPERTIES, ANALOGS AND SYNTHESIS THEREOF FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC (CA) 2012-12-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140336259-A1 PHENOLIC COMPOUNDS WITH ANTIOXIDANT AND ANTI-CANCER PROPERTIES, ANALOGS AND SYNTHESIS THEREOF GPX1, CAT, GPX4 FDPS 752/4885SMN1; SMN2 2427/4885PPARG 1110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.